Actualités

Salesforce app gains deeper autonomous workflow features.

Brookfield Corp. (BN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Shares of Advanced Micro Devices (NASDAQ:AMD) traded near $521 midmorning Wednesday, roughly flat on the session after a prior close near $520. The quiet tape masks a loud catalyst: UBS just supersized its price target on AMD stock to $670 from $455, one of the more aggressive upward revisions on the Street this month. The ... Wall Street Just Supersized Its Price Target on AMD. Is the Stock Still Too Cheap?

Siri's rejuvenation is unlikely to boost the iPhone's market share.

The stock market may have hit a wall, but the S&P 500 price targets keep going higher. The strategists at J.P. Morgan were the latest to raise their target: Dubravko Lakos-Bujas of J.P. Morgan wrote in a note Wednesday that he and his team were upping their year-end target to 7800 from 7600. The S&P 500 was up 0.2% to about 7383 on Wednesday.

Salesforce, Inc. (NYSE:CRM) is one of the 15 AI Stocks Analysts Are Watching: Microsoft, Nvidia, and More. One AI stock Wall Street is bullish on based on its depressed valuation, attractive margin profile, and robust cash flow is Salesforce, Inc. (NYSE:CRM). On June 18, Monness, Crespi, Hardt analyst Brian White upgraded the stock to “Buy” […]

International Business Machines Corporation (NYSE:IBM) is one of the 15 AI Stocks Analysts Are Watching: Microsoft, Nvidia, and More. On June 23, JPMorgan upgraded International Business Machines Corporation (NYSE:IBM) to Overweight from neutral and hiked its price target to $291 from $270. The firm said it sees “software acceleration” for the stock and that there […]

Enphase Energy (NASDAQ:ENPH) is one of the 15 AI Stocks Analysts Are Watching: Microsoft, Nvidia, and More. The data center power market holds significant opportunity, and Enphase Energy is one name that could benefit from it. On June 18, Barclays analyst Christine Cho upgraded the stock from Underweight to Equal weight with a price target […]

We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Amgen Inc. (NASDAQ:AMGN) is one of the best weight loss drugs on this list. TheFly reported on June 16 that Mizuho analyst Salim Syed increased the price target for AMGN to $303 from $295 while maintaining a Neutral rating on […]

Wells Fargo analysts believe AMAT has more room to run amid the ever-increasing demand for semiconductor equipment and AI infrastructure buildouts.

Salesforce, Inc. (NYSE:CRM) is one of the best big tech stocks to buy according to Wall Street analysts. Salesforce, Inc. (NYSE:CRM) was upgraded by Monness Crespi to Buy from Neutral on June 18, with the firm setting a price target of $200. It stated that with a 41% decline, the company has “earned the unflattering title […]

Nutrien Ltd. (NYSE:NTR) is one of the top cheap growth stocks to get rich. Berenberg downgraded Nutrien Ltd. (NYSE:NTR) to Hold from Buy on June 10 and adjusted the price target on the stock to $65, up from $61. It told investors in a research note that the company is likely to deliver another year of […]

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the top high-conviction stocks to buy according to hedge funds. Deutsche Bank cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $366 from $440 on June 2 while maintaining a Sell rating on the shares. The stock also received a rating update from BofA on May 12, […]

A lengthy dividend growth streak also usually means high quality, income stability, and the potential for above-average total returns over time.

Citizens has raised its price target on Backblaze to $14 from $8 and kept an ‘Outperform’ rating on the stock, according to TheFly.

An analysis of 30 of the most-hyped, tech-driven initial public offerings (IPOs) since May 2012 bodes poorly for SpaceX.

AbbVie’s model fair value is held at US$253.55 per share, signaling no change to the core price target after factoring in the proposed Apogee Therapeutics acquisition. Research around the US$10.9b deal points to a split view, with some analysts highlighting the immunology and atopic dermatitis opportunity, while others question how much value the company can capture against rising competition. As you read on, you will see how these mixed signals are shaping the evolving AbbVie story and what...

International Business Machines Corp. (NYSE:IBM) is one of the 10 Resilient Stocks Beating Market Slump. International Business Machines saw its share prices climb by 5.04 percent on Tuesday to close at $264.94 apiece, after JPMorgan turned bullish for its stock, thanks to the rosy prospects for its software business. In a market note, JPMorgan upgraded […]

I've covered Micron repeatedly, and each time, the story has been some version of the same thing. The artificial intelligence (AI) memory supercycle is getting bigger than the market expected, and Micron keeps proving the bears wrong. Tuesday, June 23, is a jarring interruption. MU dropped more ...

Axon Enterprise recently reported strong Q1 2026 results, raised its full-year revenue outlook, and continued winning long-term public safety contracts while facing local political controversy in Scottsdale over a proposed development project. The company is rapidly building an AI-powered public safety platform, spanning TASER 10, Axon Body 4, counter-drone systems, and tools like Axon Assistant and Axon Vision, that aims to lock in agencies through integrated hardware, software, and cloud...

Schrödinger, Inc. (NASDAQ:SDGR) is among the Best Pharmaceutical Stocks. On May 14, Morgan Stanley lowered its price target on Schrödinger, Inc. (NASDAQ:SDGR) to $17 from $19. The firm maintained an “Equal Weight” rating on the shares. Separately, Schrödinger, Inc. (NASDAQ:SDGR) maintained full-year guidance for ACV of $218 million to $228 million. The corporation expects 10% to […]

Generate Biomedicines, Inc. (NASDAQ:GENB) is one of the 12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On. On May 14, Morgan Stanley increased its price objective on Generate Biomedicines, Inc. (NASDAQ:GENB) to $22 from $20. The firm maintained an “Overweight” rating on the shares. Separately, Generate Biomedicines, Inc. (NASDAQ:GENB)’s GB-0895 (anti-TSLP) program […]

Booking Holdings Inc. (NASDAQ:BKNG) is one of the most promising long-term stocks to buy according to analysts. On June 3, Priceline, a subsidiary and primary brand of Booking Holdings, upgraded its AI travel assistant, Penny, by integrating Anthropic’s Claude into its proprietary tech stack. This agentic tool allows users to move from initial travel ideas […]

Take-Two Interactive Software Inc (NASDAQ:TTWO) shares could see a stronger long-term monetization profile from the next iteration of Grand Theft Auto Online (GTAO), according to Bank of America, which raised its price objective on the stock and upgraded its forward bookings assumptions for the...

Lam Research is in focus as Citi’s $450 price target highlights the company’s potential from surging NAND demand.

BofA hiked its price target on Micron to $1,500 from $950, while keeping a ‘Buy’ rating.

SK hynix Inc. (OTC:HXSCL) is one of the fastest-growing high-bandwidth memory stocks to buy. The company gave the list one of its most direct HBM catalysts on June 17, 2026, when it shipped samples of 12-layer HBM4E to major customers. SK hynix said the next-generation AI memory reaches up to 16 Gbps per pin, improves […]

On Holding (ONON) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Boston Scientific Corp. (NYSE:BSX) is one of the 10 oversold stocks offering high upside. On June 12, Matt O’Brien from Piper Sandler reduced the target price on Boston Scientific Corporation (NYSE:BSX) from $90 to $65, resulting in an adjusted upside potential of close to 45% at the current level. The analyst retained an Overweight rating […]

Chewy Inc. (NYSE:CHWY) is one of the 10 oversold stocks offering high upside. On June 12, Citi reaffirmed a Buy rating for Chewy Inc. (NYSE:CHWY) while reducing the price target from $37 to $31. Despite the downward adjustment, the estimated price target still results in an upside of almost 75%. According to the firm, the […]